Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05281172
Other study ID # PID2019-110400RB-I00
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 21, 2022
Est. completion date June 30, 2024

Study information

Verified date May 2024
Source Universidad Miguel Hernandez de Elche
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study corresponds to a pretest-posttest randomized experimental design with two arms. Arm 1 includes Guided Self-Change program, and Arm 2 a psychoeducational program to promote healthy habits. This study aims to analyze the efficacy of a selective and indicated prevention program based on the Guided Self-Change model (GSC) in adolescent alcohol users between 16-18 years. Researchers hypothesize that implementation of GSC therapy will lead to a greater reduction of alcohol drinkers compare with the control condition, and will prevent alcohol abuse after 6 and 12 months.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 800
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 16 Years to 18 Years
Eligibility Inclusion Criteria: - 16-18 years old. - Having inform consent from parents - Report using alcohol at least once a month during the previous last three months Exclusion Criteria: - Participants will be excluded if they refer being diagnosed with a severe mental disorder. - Have a severe medical illness that will limit participation - Being under treatment for a psychological of psychiatric problem. - Meet DSM criteria for Drug dependence to illegal drugs.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Guided Self-Change therapy (GSC)
The GSC program follows a motivational cognitive-behavioral approach designed to minimize resistance in drug behavior changes, prevent relapse risk, and increase motivation to quit. The GSC consists of 5 weekly sessions of 50 minutes delivered in groups of 20-25 people.
Psychoeducation program about healthy habits
The psychoeducational program will include talks about healthy habits such as physical activity, relaxation, and sleep hygiene. This intervention consists of 5 weekly sessions of 50 minutes delivered in groups of 20-25 people.

Locations

Country Name City State
Spain José Luis Carballo Elche Alicante

Sponsors (2)

Lead Sponsor Collaborator
Universidad Miguel Hernandez de Elche Spanish Ministry of Science, Innovation, and Universities

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Alcohol use change Alcohol use will be assessed using the Timeline Follow-Back (Sobell & Sobell, 1992) Change from baseline up to 5 weeks and two follow-ups at 6 and 12 months post intervention
Primary Alcohol abuse Alcohol abuse will be assessed using the Rutgers Alcohol Problem Index (White & Labouvie, 1989). The global score ranges from 0 to 69, where higher scores represent greater level of alcohol-related problems. Change from baseline to week 5, and at 6 and 12 months post intervention.
Primary Alcohol dependence Alcohol dependence will be assessed with the Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (Grant et al., 2015). Change from baseline to week 5, and at 6 and 12 months post intervention.
Secondary Drug use Assessed with the Drug History Questionnaire (Sobell et al., 1995). Change from baseline to week 5, and at 6 and 12 months post intervention.
Secondary Impulsiveness Impulsiveness will be assessed with the Impulsive Behavior Scale (Cyders et al., 2014). The global score ranges from 20 to 80, where higher scores represent greater level of impulsivity. Change from baseline to week 5, and at 6 and 12 months post intervention.
Secondary Sleep quality Sleep will be assessed with different sleep measures, such as the Brief version of the Pittsburgh Sleep Quality Index (Sancho-Domingo et al., 2021). The global score of the B-PSQI ranges from 0 to 15, where higher scores represent poor sleep quality. Change from baseline to week 5, and at 6 and 12 months post intervention.
See also
  Status Clinical Trial Phase
Completed NCT03892369 - FGF21 and Its Role in Alcohol Dependence N/A
Completed NCT01615497 - Web-based CBT4CBT for Alcohol N/A
Recruiting NCT03848000 - Examination of Whether an Exercise Programme Reduces Alcohol Consumption Among Alcohol-Dependent Adults N/A
Terminated NCT04094584 - Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use Disorder Phase 4